Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Equity (2018 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Return on Equity for 9 consecutive years, with 0.39% as the latest value for Q1 2026.

  • For Q1 2026, Return on Equity fell 36.0% year-over-year to 0.39%; the TTM value through Mar 2026 reached 0.39%, down 36.0%, while the annual FY2025 figure was 0.32%, 34.0% down from the prior year.
  • Return on Equity hit 0.39% in Q1 2026 for Bicycle Therapeutics, down from 0.37% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.01% in Q4 2024 and bottomed at 0.61% in Q2 2023.
  • Average Return on Equity over 5 years is 0.31%, with a median of 0.34% recorded in 2022.
  • Year-over-year, Return on Equity soared 48bps in 2024 and then crashed -38bps in 2025.
  • Bicycle Therapeutics' Return on Equity stood at 0.41% in 2022, then fell by -14bps to 0.47% in 2023, then surged by 103bps to 0.01% in 2024, then crashed by -2906bps to 0.37% in 2025, then dropped by -6bps to 0.39% in 2026.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.39%, 0.37%, and 0.11% for Q1 2026, Q4 2025, and Q3 2025 respectively.